Choksi Asia (BOM:530427) Marketable Securities: ₹ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530427 Choksi Asia Ltd BOM:530427
49 GF Score
Price ₹228.70
! 4 Warning Signs
View Full Analysis

What is Choksi Asia Marketable Securities?

Choksi Asia BOM:530427 -0.54% 49 Marketable Securities is ₹ Mil as of Jun. 2026. GuruFocus rates BOM:530427 with a GF Score™ of 49/100. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Choksi Asia's Marketable Securities for the quarter that ended in Jun. 2026 was ₹ Mil.

Choksi Asia's annual Marketable Securities declined from Mar. 2024 (₹106.7 Mil) to Mar. 2025 (₹88.3 Mil) and declined from Mar. 2025 (₹88.3 Mil) to Mar. 2026 (₹0.0 Mil).

Choksi Asia  (BOM:530427) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Choksi Asia Marketable Securities Related Terms

Choksi Asia Marketable Securities Historical Data

* Premium members only.

The historical data trend for Choksi Asia's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Choksi Asia Marketable Securities Chart

Choksi Asia Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.50 37.95 106.66 88.34 0.00

Choksi Asia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.00 - 0.00 -
BOM:530427
49GF Score
Choksi Asia Ltd BOM:530427
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Choksi Asia Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹ Mil mean?
Choksi Asia (BOM:530427) has a Marketable Securities of ₹ Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Choksi Asia and its competitors.
Is Choksi Asia's Marketable Securities too high?
Choksi Asia's current Marketable Securities is ₹ Mil. Overall, Choksi Asia has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Choksi Asia's Marketable Securities compare to ABT and SYK?
Choksi Asia's Marketable Securities of ₹ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Choksi Asia and its competitors. Choksi Asia's current Marketable Securities is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Choksi Asia stock overvalued right now?
Choksi Asia (BOM:530427) has a current Marketable Securities of ₹ Mil. The current Marketable Securities is ₹ Mil. Choksi Asia's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Choksi Asia (BOM:530427), the current Marketable Securities is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Choksi Asia Business Description

Address Nehru Road, No. 163/164, Choksi Bhuvan, Ville Parle (East), Mumbai, MH, IND, 400057
Choksi Asia Ltd formerly Choksi Imaging Ltd is an India-based company engaged in the manufacturing of photosensitized materials, medical X-rays, and other healthcare products. The company sells and derives revenue from products like X-ray films, ultrasound, computed radiography systems, specialty X-ray films, etc. In addition, the company also offers maintenance services for X-ray processors, equipment, and computer radiography systems. The firm provides various photographic, and ultrasonic sound services in association with Protec, Medtron, and others.
49GF Score

Get the complete analysis for BOM:530427

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹228.70
Price